Michael B. Kelly

CIK: 0002147307

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

APMD

Apnimed, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

APMD
Apnimed, Inc.
Aug 3, 2036
Disposition(D)
Stock Option (Right to Buy)
Direct
31.4K shares-
APMD
Apnimed, Inc.
Aug 3, 2036
Award(A)
Stock Option (Right to Buy)
Direct
31.4K shares-
APMD
Apnimed, Inc.
Jul 30, 2036
Award(A)
Stock Option (Right to Buy)
Direct
31.4K shares-
APMD
Apnimed, Inc.
Aug 3, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
333.6K shares-
APMD
Apnimed, Inc.
Aug 3, 2026
Award(A)
Stock Option (Right to Buy)
Direct
333.6K shares-

		Type	Shares	Price		Ownership
Aug 3, 2036	APMD Apnimed, Inc.	Disposition(D) Stock Option (Right to Buy)	31,434	-	-	Direct
Aug 3, 2036	APMD Apnimed, Inc.	Award(A) Stock Option (Right to Buy)	31,434	-	-	Direct
Jul 30, 2036	APMD Apnimed, Inc.	Award(A) Stock Option (Right to Buy)	31,434	-	-	Direct
Aug 3, 2026	APMD Apnimed, Inc.	Disposition(D) Stock Option (Right to Buy)	333,580	-	-	Direct
Aug 3, 2026	APMD Apnimed, Inc.	Award(A) Stock Option (Right to Buy)	333,580	-	-	Direct

1-5 of 5 transactions

About Kelly Michael B

Kelly Michael B (SEC CIK 0002147307) files insider reports with the SEC as Chief Financial Officer of Apnimed, Inc. (APMD).

Signal8 holds 2 ownership filings by Kelly Michael B (1 Form 3, 1 Form 4), filed between Jul 30, 2026 and Aug 3, 2026. Those filings report 5 transactions, the latest on Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kelly Michael B's filings is in CAMBRIDGE, MA.

Recent filings by Kelly Michael B

Aug 3, 2036: Disposition to issuer transaction of APMD derivative securities (Form 4, code D).
Aug 3, 2036: Grant or award of APMD derivative securities (Form 4, code A).
Jul 30, 2036: Grant or award of APMD derivative securities (Form 4, code A).
Aug 3, 2026: Disposition to issuer transaction of APMD derivative securities (Form 4, code D).
Aug 3, 2026: Grant or award of APMD derivative securities (Form 4, code A).

Other insiders filing for Apnimed, Inc. (APMD)

Morningside Venture Investments Ltd, 10% Owner
Alpha Wave Ventures GP, Ltd, 10% Owner
Lind Kevin Robert, Chief Executive Officer
FONTEYNE PAUL R., Director
Sender Gary, Director
SEKHRI PAUL J, Director

How to read Form 4 transaction codes